12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry-Reference-Cited by-同舟云学术

12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry

Published:2021-09-13 Issue: Volume: Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Niedzwiecki Mateusz¹,Hunt Adrian²³^ORCID,Nguyen Vuong³,Mehta Hemal³⁴,Creuzot‐Garcher Catherine⁵,Gabrielle Pierre‐Henry³⁵^ORCID,Guillemin Martin⁵,Fraser‐Bell Samantha³,Arnold Jennifer⁶,McAllister Ian L.⁷,Gillies Mark³,Barthelmes Daniel¹³

Affiliation:

1. Department of Ophthalmology University Hospital Zurich & University of Zurich Zurich Switzerland

2. Department of Ophthalmology Westmead Hospital Westmead NSW Australia

3. The Save Sight Institute Sydney Medical School The University of Sydney Sydney NSW Australia

4. Ophthalmology Department Royal Free London NHS Foundation Trust London UK

5. Department of Ophthalmology Dijon University Hospital Dijon France

6. Marsden Eye Specialists Parramatta NSW Australia

7. Centre for Ophthalmology and Visual Science Lions Eye Institute The University of Western Australia Perth WA Australia

Funder

National Health and Medical Research Council

Royal Australian and New Zealand College of Ophthalmologists

Publisher